期刊文献+

受体酪氨酸激酶EphA7基因在胃癌中的表达及意义 被引量:3

Expression of receptor tyrosine kinase EphA7 in gastric carcinoma and its clinical significances
下载PDF
导出
摘要 目的:基因是受体酪氨酸激酶(RTK)基因家族中最大的亚族。文中通过CpG岛高甲基化是导致EphA7基因在结直肠癌中表达下调的重要机制。检测EphA7基因mRNA在胃癌组织中的表达水平,探讨其对胃癌发生、发展及预后的意义。方法:利用荧光标记探针进行实时定量RT-PCR,测定62例胃癌患者的癌组织及癌旁非癌组织标本中EphA7 mRNA表达水平,结合临床病理学指标进行统计学处理,分析EphA7基因在胃癌组织和正常胃黏膜中表达水平与临床病理资料之间的关系。结果:EphA7基因表达水平在不同胃癌患者的癌组织标本和癌旁非癌胃黏膜中呈现差异性表达。根据EphA7在癌组织和癌旁非癌胃黏膜中的表达水平,可分为3种类型:正常黏膜/癌组织mRNA表达比值(N/T)(0.5为表达上调(22/62),(2为表达下调(27/62),介于0.5和2之间为表达无差异(13/62)。EphA7 mRNA表达与患者年龄有关(P=0.030),亦与肿瘤分期有关(P=0.031)。EphA7表达上调与肿瘤转移有一定的相关性(P=0.063)。结论:EphA7基因表达水平在不同的胃癌患者中有很大差异。EphA7基因表达上调可能在胃癌的发生和疾病进展中起一定作用。 Objective : Eph is the largest member of the family of receptor tyrosine kinases (RTK). Hypermethylation of CpG island is an important mechanism leading to down-regulation of EphA7 in gastric cancer. The objective of this study is to investigate the expression level of EphA7 in gastric carcinoma and its roles in the development, progression and prognosis of gastric carcinoma. Methods : The expression level of EphA7 transcript in gastric carcinoma specimens and normal mucosa tissues was detected using real-time RT-PCR. Results: The expression level of EphA7 in gastric carcinoma was divided into three groups according to the expression rate in gastric cancer tissue and matched normal mucosa. Statistics analysis showed that the expression of EphA7 is significantly related to age and stage. Overexpression of EphA7 has a tendency to relate to metastasis. Conclusion: EphA7 is differentially expressed in gastric carcinoma specimens. Overexpression of EphA7 may play a role in the development and progress of gastric carcinoma.
出处 《医学研究生学报》 CAS 2009年第3期260-263,共4页 Journal of Medical Postgraduates
基金 国家基础研究项目973资助基金(批准号:2006 CB705707) 南京军区医学科学技术研究"十一五"计划重点课题(批准号:06Z37)
关键词 EPHA7 受体酪氨酸激酶 实时定量RT—PCR 胃癌 EphA7 Receptor tyrosine kinase Real-time RT-PCR Gastric carcinoma
  • 相关文献

参考文献12

  • 1Hirai H, Maru Y, Hagiwara K, et al. A novel putative tyrosine kinase receptor encoded by the eph gene [J]. Science, 1987, 238 (4834) : 1717-1720.
  • 2Stephen LJ, Fawkes AL, Verhoeve A, et al. A critical role for the EphA3 receptor tyrosine kinase in heart development [J]. Dev Biol, 2007, 302( 1 ) :66-79.
  • 3Segura I, Essmann CL, Weinges S, et al. Grb4 and GIT1 transduce ephrinB reverse signals modulating spine morphogenesis and synapse formation [J]. Nat Neurosci, 2007, 10(3) :301-310.
  • 4王建东,周晓军.酪氨酸激酶受体Eph基因及其与肿瘤的关系[J].医学研究生学报,2006,19(10):935-938. 被引量:9
  • 5王建东,周晓军.高甲基化导致EphA7基因在结直肠癌中低表达[J].医学研究生学报,2007,20(1):6-9. 被引量:14
  • 6Wang J, Dong Y, Shen Z, et al. Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis [ J]. Oncology, 2007,73(3-4) :238-245.
  • 7Thaker PH, Deavers M, Celestino J, et al. EphA2 expression is associated with aggressive features in ovarian carcinoma [ J ]. Clin Cancer Res, 2004, 10( 15 ) :5145-5150.
  • 8Herath NI, Spanevello MD, Sabesan S, et al. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival [ J ]. BMC Cancer, 2006, 6 : 144.
  • 9Herrem CJ, Tatsumi T, Olson KS, et al. Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma [ J ]. Clin Cancer Res, 2005, 11(1) :225-231.
  • 10Wang J, Kataoka H, Suzuki M, et al. Downregulation of EphA7 by hypermethylation in colorectal cancer [ J ]. Oncogene, 2005, 24(36) :5637-5647.

二级参考文献42

  • 1薛春雨,邢新,李蠡,李军辉,蒋平.酪氨酸酶在自体中厚移植皮片中的表达[J].医学研究生学报,2005,18(5):388-390. 被引量:9
  • 2孙正,祁晓平,许哲,李刚,陈彻,黎介寿.Flt-3配体对树突状细胞融合疫苗的制备和抗结直肠癌效应的影响[J].医学研究生学报,2006,19(4):306-309. 被引量:4
  • 3王建东,周晓军.酪氨酸激酶受体Eph基因及其与肿瘤的关系[J].医学研究生学报,2006,19(10):935-938. 被引量:9
  • 4王建东,周晓军.高甲基化导致EphA7基因在结直肠癌中低表达[J].医学研究生学报,2007,20(1):6-9. 被引量:14
  • 5Hirai H, Maru Y, Hagiwara K, et al. A novel putative tyrosine kinase receptor encoded by the eph gene[J]. Science, 1987,238(4834) : 1717-1720.
  • 6Tessier-Lavigne M. Eph receptor tyrosine kinases, axon repulsion, and the development of topographic maps[J]. Cell, 1995,82 ( 3 ) : 345-348.
  • 7Winslow JW, Moran P, Valverde J, et al. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation[J]. Neuron, 1995,14(5):973-981.
  • 8Wang HU, Anderson DJ. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth[J]. Neuron, 1997,18(3) : 383-396.
  • 9Adams RH, Wilkinson GA, Weiss C, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis,and sprouting angiogenesis [J]. Genes Dev, 1999,13 ( 3 ) : 295-306.
  • 10Gerety SS, Wang HU, Chen ZF, et al. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development [J].Mol Cell,1999,4 ( 3 ) :403-414.

共引文献23

同被引文献53

  • 1Tsai YY,Chang KC,Lee H,et al.Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium[J].Clin Experiment Ophthalmol,2005,33(1):60-62.
  • 2Tsai YY,Chang KC,Lin CL,et al.p53 Expression in pterygium by immunohistochemical analysis:A series report of 127 cases and review of the literature[J].Cornea,2005,24(5):583-586.
  • 3Demirok A,Simsek S,Ozdemir M,et al.Effect of pterygium surgery on corneal topography[J].Cornea,2005,24(4):505-506.
  • 4Yagmur M,Ozcan AA,Sari S,et al.Visual acuity and corneal topographic changes related with pterygium surgery[J].J Refract Surg,2005,21(2):166-170.
  • 5Errais K,Bouden J,Mili-Boussen I,et al.Effect of pterygium surgery on corneal topography[J].Eur J Ophthalmol,2008,18(2):177-181.
  • 6Mohammad-Salih PA,Sharif AF.Analysis of pterygium size and induced corneal astigmatism[J].Cornea,2008,27(4):434-438.
  • 7Takahagi RU,Goncalves F,Yamamoto RK,et al.Eyeblink rate before and after pterygium exeresis[J].Arq Bras Oftalmol,2008,71(3):381-384.
  • 8Balogun MM,Ashaye AO,Ajayi BG,et al.Tear break-up time in eyes with pterygia and pingueculae in Ibadan[J].West Afr J Med,2005,24(2):162-166.
  • 9Zhivov A,Beck R,Guthoff RF.Corneal and conjunctival findings after mitomycin C application in pterygium surgery:An in-vivo confocal microscopy study[J].Acta Ophthalmol,2009,87(2):166-172.
  • 10Papadia M,Barabino S,Valente C,et al.Anatomical and immunological changes of the cornea in patients with pterygium[J].Curr Eye Res,2008,33(5):429-434.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部